Zoll Medical’s Zenix monitor/defibrillator has received premarket approval (PMA) from the US FDA, according to the company.
The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations.
Equipped with Zoll’s innovative Real BVM Help® and exclusive Real CPR Help technology, Zenix gives healthcare providers real-time clinical feedback to improve ventilation quality and deliver high-quality CPR.1 The advanced technology of Zenix empowers EMS teams and hospital clinicians to make informed, confident decisions and ensure they are delivering exceptional patient care, every time.
“Whether you are a hospital clinician or an EMS professional, the Zoll Zenix monitor/defibrillator is designed to work the way you work,” said Elijah White, President of Zoll Acute Care Technology. “Zenix is our most advanced monitor/defibrillator, and yet it’s incredibly easy to use—virtually all functions of the device are accessible with three screen-touches or less. Along with the X Series and R Series, Zenix extends Zoll’s leadership in professional monitors/defibrillators with unique features and intuitive design.”
The Zenix monitor/defibrillator is available now to customers in the US and Canada.
Reference from Zoll
- Drennan et al. 10.1016/j.resuscitation.2024.110381. https://pubmed.ncbi.nlm.nih.gov/39299509/
Images: Zoll Asahi Kasei Zenix defibrillator monitor via https://www.businesswire.com/news/home/20251009415956/en/Asahi-Kasei-Elevates-Critical-Care-Solutions-with-FDA-Approval-of-ZOLLs-Zenix-MonitorDefibrillator
